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A B S T R A C T
Prostaglandin (PGE2 and PGI2) synthesis was determined in the cerebrospinal fluid (CSF) and serum of 19 hypoxic
neonates at the age of 5–96 hours by using Enzyme Linked Immunosorbent Assay (ELISA) method. Control group con-
sisted of 8 children of the same age whose samples were taken due to initial suspicion of neonatal meningitis. The prosta-
glandin concentrations in CSF were correlated with initial hypoxic-ischemic encephalopathy (HIE) stage and neurologi-
cal findings of patients at the age of 12 months. The values of PGE2 and PGI2 in the CSF of children with perinatal
hypoxia (PNH) were significantly higher than in the children from the control group. The values of PGI2 in serum were
significantly higher than in »CSF« of patients with PNH. Although average values of PGE2 and PGI2 in the liquor were
higher in children with advanced stage of HIE, the differences between different stages were not statistically significant.
We did not find any significant correlation between average concentrations of prostaglandins and neurological findings
of the 12-month-old children.
Key words: prostaglandins (PG), perinatal hypoxia (PNH), hypoxic-ischemic encephalopathy (HIE), cerebrospinal
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Introduction
Perinatal hypoxia (PNH) is, still, nowadays, when
perinatal care is improved, very important clinical prob-
lem because of possible, early and late, consequences for
child1,2. Clinical signs of central nervous system (CNS) in
the form of hypoxic-ischemic encephalopathy (HIE) are
very important, early symptoms in neonatal clinical prac-
tice3. Late signs of perinatal hypoxia are manifested very
clearly at the age of 12 months in the form of more or less
obvious motoric or mental disorders4,5.
Pathophysiological base of damage in PNH means ex-
haustion of mechanism of circulatory and metabolic ad-
aptation of fetus or neonate to hypoxic-ischemic stress6.
Signs of CNS dysfunction in form of HIE which are
graded, according to Sarnat/Sarnat method, in three
grades, can be important predictor of later damages7,8.
Prostaglandins (PG) are derivatives of arachidonic acid
which rises in the process of phospholipids tissue mem-
branous breakdown. PGI2, PGE2 and PGF29–11 have es-
pecially important biological effect. There are a number
of unidentified processes in which some representatives
of this group are included. Vasodilatory effect of some
PGs is an important mechanism in compensatory phase
of hypoxic-ischaemic brain damage. However, their dy-
namics and possible consequences on early and late neu-
rological outcome are still insufficiently defined and they
are still subject to researches12–14.
Patients and Methods
In the period from 2003 to 2005, a prospective cohort
analysis of vasodilatory mediators of hypoxia (PGE2 and
PGI2) has been carried out on neonates, hospitalized at
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Neonatal Intensive Care Unit of Children’s department,
University Hospital Mostar, due to perinatal hypoxia.
Only neonates who fulfilled at least three of the following
criteria for perinatal hypoxia/asphyxia (American Pedi-
atric Academy – APA) were included in the study13: 1.
Birth distress evaluated on cardiotocography (more than
an hour of serious disorders, deceleration or bradycardia
longer than half an hour); 2. Early passage of thick
meconium; 3. pH in fetal scalp blood lower than 7.2 or in
capillary blood in the first four hours lower than 7.25. 4.
Need for neonatal resuscitation with positive pressure
ventilation for more than one minute; 5. Apgar score £7
in the fifth minute of life; 6. Abnormal neurological signs
in the first 72 hours of life (abnormal tonus, reflexes and
consciousness); 7. Multi-system perinatal failure. Neo-
nates with infection confirmed, and those with congeni-
tal malformations or metabolic disorders, as well as cases
with artificial hemorrhage (traumatic hemorrhage at
lumbar puncture) were excluded.
Control group was formed from non-asphyxic/non-
hypoxic neonates who underwent spinal tap and were
treated hematologically, due to clinical suspicion on peri-
natal infection. Cerebrospinal fluid (CSF) and blood mi-
crobial cultures were negative. PGE2 was determined in
CSF samples of 19 patients at the age of 5–96 hours, and
of 8 examinees of the control group. PGI2 was deter-
mined in CSF samples of 19 patients and in serum of 9
patients. It was not determined in the serum of control
examinees because of insufficient sample quantity. Pa-
tients and participants of control group were not signifi-
cantly different in birth weight, sex, gestational age, pro-
teins in CSF and cells in CSF. There was a significant
difference between patients with PNH and control group
for Apgar score in the first and the fifth minute of life, for
blood pH, pCO2 and base excess (–EB). pO2 was not sig-
nificantly different between groups as artificial ventila-
tion with oxygen was applied immediately after birth
(Table 1). CSF samples were taken from patients at the
age of 5–96 hours and they were stored at –20 °C in
Chemical-Biological laboratory of The School of Medicine
in Mostar, and at –70 °C at Department of Physiology of
the School of Medicine, University of Zagreb, prior to
analysis. Prostaglandin PGE2 was determined according
to Enzime Linked Immunosorbent Assey (ELISA) me-
thod using original R&D kit (Catalog no. RD-DE2100).
PGI2 was determined according to ELISA method using
the kit of the same producer (Catalog no. RD-DE1700),
and values are expressed in pg/mL. Optical reader for
microplates of Dynatech Company (M 5000) was used for
result reading.
Patients were clinically observed and their neurologi-
cal status was evaluated according to Sarnat/Sarnat me-
thod7 as: 1-mild HIE (1st grade of HIE) (excitation, em-
phatic reflexes, frequent convulsions); 2-moderate HIE
(2nd grade of HIE) (lethargy, diminished reflexes, con-
vulsions +/–); 3-severe HIE (3rd grade of HIE) (stu-
por/coma, absence of reflexion, convulsions +).
Neurological status of the 12-month-old was esti-
mated by neuropediatricians and physiotherapists and
the patients were classified, according to Amiel-Tison
method5, into three groups: 1-normal result; 2-mild mo-
toric damage (abnormality in muscular tonus); 3-abnor-
mal result (cerebral palsy or death). Ultrasound exami-
nation of brain, (at mobile Ultrasound Toshiba instru-
ment, with probe of 3.75 mHz, 5 and 6 mHz) made dur-
ing the first week, was used in total estimation of neuro-
logical state of a neonate.
Statistical analysis was made by using Statistica for
Windows programme, Version 7. StatSoft, Inc. (2004).
Non-parametric statistic tests (Kruskal-Wallis, Mann-
Whitney U test) were used, and results were considered
statistically significant if p£0,0515.
The research was approved by Ethical Committee of
the School of Medicine, University of Mostar, with the
parents’ written consent.
Results
Group data on the asphyxia group (n=19) and the
control group (n=8) are given in Table 1. The infants in
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TABLE 1








Gestational age (weeks) 39.00 (2.75) 39.50 0.716
Birth weight (g) 3270.00 (550.00) 3000.00 0.386
Apgar score (1st minute) 6.00 (2.00) 8.00 (2.00) <0.001
Apgar score (5th minute) 7 (1.00) 10 (2.00) <0.001
CRP (mg/L) 1.9 (5.50) 4.25 (4.20) 0.591
Proteins in CSF (mg/mL) 1082.0 (1284.0) 721.0 (962.75) 0.911
Blood pH (capillary) 7.23 (0.08) 7.34 (0.19) 0.016
pCO2 (mmHg) 58.40 (15.70) 41.10 (18.88) 0.016
pO2 (mmHg) 48.00 (10.40) 56.05 (23.13) 0.689
–EB 7.30 (2.30) 2.25 (1.58) 0.002
IQR – interquartile range, PNH – perinatal hypoxia, CRP – C reactive protein, CSF – cerebrospinal fluid, EB – excess base
the asphyxia group were classified as having mild (n=9),
moderate (n=7) and severe HIE (n=3). Two infants in
the group with severe HIE died in the neonatal period
due to multiorgan postasphyctic failure. Other infants
have been followed during 12 months of age. Six infants
have normal neuromotor outcome, eight infants at the
age of 12 months have mild motor impairment. Five in-
fants, one from severe HIE group, other from moderate
HIE group, have adverse neuromotor outcome (cerebral
palsy).
Significantly higher values of PGE2 were found in
CSF samples of children with PNH than those in the con-
trol group (p=0.0476, Mann-Whitney U test) (Table 2).
Patients also had significantly higher PGI2 values in
CSF than examinees in the control group (p=0.0215,
Mann-Whitney U test) (Table 3). Average values of PGI2
are significantly higher in the serum of patients than in
CSF (Table 3), while, there are no comparable results in
the control group because of little sample quantity.
Children with 3rd grade of HIE had higher average
values of PGE2 and PGI2 in CSF than children with 1st
and 2nd grade, but differences were not statistically sig-
nificant (Table 4). Average concentrations of PGE2 were
not significantly different comparing to neurological re-
sult at the age of 12 months. Average values of PGI2 were
obviously higher at children with good neurological re-
sult, but difference between groups was not statistically
significant (Table 5). In serum also, there was not statis-
tically significant difference in average concentrations of
PGI2 between groups with different neurological results
(Table 5).
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TABLE 2
PGE2 LEVELS (pg/mL) IN CSF OF PATIENTS WITH PNH AND






Statistical significance p= 0.0476
PGE2 – Prostaglandin E2, CSF – cerebrospinal fluid,
PNH – perinatal hypoxia
TABLE 3









Patients 19 86.02 9 497.64
Controls 7 22.21 7 n.d.
Statistical significance p=0.0215
PGI2 – Prostaglandin I2, CSF – cerebrospinal fluid, n.d. – not determined
TABLE 4
VALUES OF VASODILATORY PROSTAGLANDINS (MEDIANS) IN RELATION TO GRADE OF HIE (KRUSKAL-WALLIS TEST, p<0.05)
Prostaglandin (pg/mL)
Ist grade of HIE
(N=9)
IInd grade of HIE
(N=7)
IIIrd grade of HIE
(N=3)
p value
PGE2 (CSF) 29.21 31.24 115.39 0.4090
PGI2 (CSF) 177.39 37.20 1209.74 0.1563
PGI2 (serum) 675.82 256.46 934.51 0.1027
HIE – hypoxic-ischemic encephalopathy, PGE2 – Prostaglandin E2, PGI2 – Prostaglandin I2, CSF – cerebrospinal fluid
TABLE 5
VALUES OF VASODILATORY PROSTAGLANDINS (MEDIANS) IN RELATION TO NEUROLOGICAL OUTCOME AT THE AGE









PGE2 (CSF) 31.74 29.19 38.65 0.811
PGI2 (CSF) 392.46 63.76 86.46 0.190
PGI2 (serum) 675.82 120.80 497.64 0.099
PGE2 – Prostaglandin E2, PGI2 – Prostaglandin I2, CSF – cerebrospinal fluid
Discussion
There are numbers of studies which confirm that
prostaglandins are significantly produced in entire peri-
natal period16–21. They are important autacoids with ma-
ny physiological and pathological influences. Results of
their secretion are conditioned by their dynamics, and
also by stress stimuli in which asphyxia/hypoxia have
special place19. They play an important role in the adap-
tation of blood vessels to the perfusion pressure changes,
to the carbonic dioxide (pCO2) and oxygen (pO2) partial
pressure changes, as well as many other functions17.
In our research, significantly higher PGE2 values we-
re found in CSF samples of children with PNH than in
the control group (p=0.047) (Table 2). Similar results,
with significantly higher values of PGE2 in CSF of chil-
dren with HIE, are stated by Vilanova et al.21, while
Reznichenko et al.22 find increase of PGE2 in the serum
of neonates with acute and chronic perinatal hypoxia.
Correlation of higher PGE2 values and grade of HIE, in
our analysis, was not statistically confirmed, but higher
values were noticed at children with 3rd grade of HIE
than in children with 1st grade (115.387 pg/mL versus
29.214 pg/mL). Also the concentration of PGE2 in CSF
and neurological result were not significantly correlated
(p=0.811). Researches on animal models show different
dynamics of certain prostaglandins secretions depending
on hypoxia duration (acute/chronic), different intensity
of secretion and different duration of high values of some
prostaglandins (that is PGE2 and PGI2)23,24. Recently, it
was shown that PGE2 is responsible for apnea and irreg-
ular breathing in hypoxic mice25.
In this research, significantly higher values of PGI2
were also found in CSF of children with PNH than in the
control group (p=0.0215), which is similar to results of
the above mentioned researches21,22. Although PGI2 val-
ues are obviously higher in children with 3rd grade of
HIE than in children with 1st grade (6,6 times higher),
difference between three groups of children with HIE is
not statistically significant. Liu et al.26 find higher values
of PGI2 in CSF of children with moderate and severe HIE
and in children with adverse neurological outcomes.
They conclude that PGI2 (with TXA2 and cAMP) is a sen-
sitive marker of serious brain damage in early phase and
it can be a good predictor of future neurological develop-
ment. Our analysis did not show statistically significant
difference between PGI2 value and neurological result at
the age of 12 months (small sample), although PGI2 val-
ues in group of children with good result were obviously
higher than those in children with moderate motoric
damage or with severe results (Table 5). These, at first
sight, controversial data could be possibly explained by
researches on neurological tissue in vitro where neuro-
protective role of PGI2 was found27,28. Cytoprotective ef-
fect of PGI2 observed in those researches, out of its vas-
cular effect, could be a possible basis for explanation of
its positive long-lasting effect after hypoxic-ischemic
brain damage27,28.
PGI2 in the serum of patients with PNH has similar
pattern as it has in CSF, that is, children with 3rd grade
of HIE had the highest values of PGI2 (Table 4). How-
ever, difference between groups was not statistically sig-
nificant. Raznichenko et al.22 also find similar values of
PGI2 in serum and CSF. Our result, which shows slightly
higher values of PGI2 in serum than in CSF, can be ex-
plained by vascular net changes in hypoxia, which are
more dominant than complete cerebral production of
prostaglandins which is reflexed in CSF23.
Contrary to results of the above mentioned authors,
in our study the increased values of PGE2 and PGI2 in
CSF of children with PNH were not in correlation with
grade of HIE and neurological outcome. This may be due
to the methodological differences in our study and in the
studies of other authors (e.g. time of sampling, grading of
HIE or neurological scoring) or to the well known protec-
tive effect of PGE2 and PGI2 in various diseases. Thus,
the increased concentration of these parameters can be
some kind of balance between their increased production
in patients with more severe disease and compensatory
effects of these agents to ameliorate the disease. These
antagonist influences can obviously abolish their correla-
tion with clinical parameters. The letter possibility mer-
rits further investigations, perhaps in animal model.
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VAZODILATACIJSKI PROSTAGLANDINI U PERINATALNOJ HIPOKSI^NOJ OZLJEDI MOZGA
S A @ E T A K
Proizvodnja prostaglandina (PGE2 i PGI2) je istra`ivana u likvorima i serumima 19 novoro|en~adi u dobi od 5–96
sati u kojih je postojala perinatalna hipoksija (PNH). Analiza je vr{ena enzimskim imunotestom (ELIZA). Kontrolnu
skupinu je sa~injavalo osmero djece iste dobi koja su zbog sumnje na novoro|ena~ki meningitis bila punktirana. Kon-
centracije prostaglandina u likvoru su upore|ivane sa stupnjem hipoksi~no-ishemi~ne encefalopatije (HIE) i s neuro-
lo{kim ishodom istih pacijenata u dobi od 12 mjeseci. Koncentracije PGE2 i PGI2 u likvoru su bile statisti~ki zna~ajno
vi{e u djece s PNH nego u djece iz kontrolne skupine. Koncentracije PGI2 u serumu su bile zna~ajno vi{e od onih u
likvoru pacijenata s PNH. Iako su prosje~ne koncentracije PGE2 i PGI2 u likvoru bile vi{e u djece s te`im stupnjem HIE,
razlike nisu bile statisti~ki zna~ajne. Nismo na{li niti statisti~ki zna~ajnije korelacije izme|u prosje~nih koncentracija
prostaglandina i neurolo{kog ishoda u dobi od 12 mjeseci `ivota.
